Delivery Order SPE2DB20D3101-SPE2DB21FK3T5

Award Date 8/27/21
Potential Completion Date 8/30/21
Potential Value $11K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.28 firm fixed-price contract is for the delivery of Vimpat 200 mg tablets. It has an ultimate completion date of September 22, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Vimpat 100 mg tablets. The contract has a ceiling value of $5,789.37 and an ultimate completion date of June 24, 2022. It is a firm fixed price contract and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with the DLA and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,500.96 issued by the Defense Logistics Agency (DLA). The contract is for the delivery of Vimpat 200 mg tablets, a pharmaceutical product used for medical treatment. The contract has a completion date of December 13, 2021 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of the pharmaceutical product Vimpat 200 mg tablets. The contract, valued at $1,071.74, is a firm-fixed-price delivery order with a completion date of November 23, 2021. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vimpat 100 mg tablets. The $1,415.46 firm fixed-price contract has an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Vimpat 50 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,514.70 and was awarded on June 22, 2022, with a completion date of June 23, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vimpat 100 mg tablets. The $4,402.44 firm-fixed-price contract has a completion date of June 9, 2022. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Vimpat 200 mg tablets. The contract has a ceiling value of $3,070.00 and an ultimate completion date of July 18, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a...
The Defense Logistics Agency (DLA) has awarded a $1,228.42 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the supply of Vimpat 100 mg tablets and has a completion date of March 20, 2023. This award is made under a larger Indefinite Delivery Contract between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Vimpat 200 mg tablets and has a ceiling value of $10,884.38. The contract is a firm fixed-price delivery order with a completion date of December 14, 2021. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK3T5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $10,542.63, is for the delivery of the pharmaceutical product Vimpat 100 MG Tablet 60S. The contract has a completion date of August 30, 2021 and is a firm fixed-price contract.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order contract is part of that larger IDC. The contract was awarded through full and open competition, with no set-aside designation.

Generated 2/27/25, 11:14 AM